Binna Liu

Title: Binna Liu - Innovator in Anti-Microbial Drug Development

Introduction

Binna Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of anti-microbial drug development. His innovative work focuses on riminophenazines, which are crucial in combating various microbial infections.

Latest Patents

Binna Liu holds a patent for "Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity." This invention relates to riminophenazines that feature heteroaromatic substitutions, particularly those with 2-heteroaryl-amino substituents. The patent outlines their preparation and application as drugs for treating microbial infections, either alone or in combination with other anti-infective treatments. The patent showcases a general representation of the 2-(heteroaryl)amino-riminophenazines.

Career Highlights

Binna Liu is currently associated with the Global Alliance for TB Drug Development. His work at this organization emphasizes the importance of developing effective treatments for tuberculosis and other infectious diseases. Liu's dedication to research and innovation has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Binna Liu collaborates with notable colleagues, including Kai Liu and Christopher Blair Cooper. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

Binna Liu's contributions to anti-microbial drug development through his innovative patents and collaborations highlight his importance in the field. His work continues to pave the way for advancements in treating infectious diseases.